Cytotherapy, 1477-2566


More filtering options
  1. 2020
  2. Technological advances in study of lung regenerative medicine: perspective from the 2019 Vermont lung stem cell conference

    Laertis Ikonomou, Darcy E Wagner, Sarah E Gilpin, Daniel J. Weiss & Amy L Ryan, 2020 Jun 2, In : Cytotherapy.

    Research output: Contribution to journalDebate/Note/Editorial

  3. 2018
  4. Multipotent Adult Progenitor Cells suppress homeostatic driven activation of T cells in vivo

    Fiona Carty, Jennifer M Corbett, Joao Paulo da Cunha, James L Reading, Timothy I M Tree, Anthony E Ting, Samantha R Stubblefield & Karen English, 2018 May, In : Cytotherapy. 20, 5 Suppl 1, p. S107

    Research output: Contribution to journalPublished meeting abstract

  5. 2014
  6. Regulation of advanced therapy medicinal products in Europe and the role of academia

    Kim F. Pearce, Martin Hildebrandt, Hildegard Greinix, Stefan Scheding, Ulrike Koehl, Nina Worel, Jane Apperley, Matthius Edinger, Andrea Hauser, Eva Mischak-Weissinger, Anne M. Dickinson & Mark W. Lowdell, 2014, In : Cytotherapy. 16, 3, p. 289-297

    Research output: Contribution to journalReview article

  7. 2009
  8. Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets.

    Ariane Tormin, Jan Claas Brune, Eleonor Olsson, Jeanette Valcich, Ulf Neuman, Tor Olofsson, Sten Eirik W Jacobsen & Stefan Scheding, 2009, In : Cytotherapy. 11, p. 114-128

    Research output: Contribution to journalArticle

  9. 2006
  10. Quality assessment of autografting by probability evaluation: model estimation by clinical end-points in newly diagnosed multiple myeloma patients

    O Roer, J Hammerstrom, Stig Lenhoff, AK Mylin, LM Knudsen, T Rasmussen & HE Johnsen, 2006, In : Cytotherapy. 8, 1, p. 79-88

    Research output: Contribution to journalArticle